Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Employment agrmnt
Quarterly results
Acq. announced
Director departure
|
|
Cogent Biosciences, Inc. (UMRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,170 options to buy
@ $9.55, valued at
$20.7k
|
|
| 10/03/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,345 options to buy
@ $9.55, valued at
$22.4k
|
|
| 07/05/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,884 options to buy
@ $11.96, valued at
$22.5k
|
|
| 07/05/2023 |
4
| Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,743 options to buy
@ $11.96, valued at
$20.8k
|
|
| 06/08/2023 |
4
| Morris Arlene (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
| 06/08/2023 |
4
| CAIN CHRISTOPHER W. (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
| 06/08/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
| 06/08/2023 |
4
| Shegog Todd (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
| 06/08/2023 |
4
| Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
| 06/08/2023 |
4
| Harwin Peter Evan (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
| 04/04/2023 |
4
| Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,900 options to buy
@ $10.75, valued at
$20.4k
|
|
| 01/04/2023 |
4
| Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,792 options to buy
@ $11.07, valued at
$19.8k
|
|
| 01/04/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,862 options to buy
@ $11.07, valued at
$20.6k
|
|
| 10/04/2022 |
4
| Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,419 options to buy
@ $14.33, valued at
$20.3k
|
|
| 10/04/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,474 options to buy
@ $14.33, valued at
$21.1k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Sachs Jessica (Chief Medical Officer) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 622 shares
@ $7.395, valued at
$4.6k
|
|
| 06/21/2022 |
4
| Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Bought 1,200,000 shares
@ $8.25, valued at
$9.9M
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,753 options to buy
@ $7.92, valued at
$21.8k
|
|
| 04/05/2022 |
4
| Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,650 options to buy
@ $7.92, valued at
$21k
|
|
| 01/27/2022 |
4
| Green John L. (CFO) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 225,000 options to buy
@ $7.6, valued at
$1.7M
|
|
| 01/27/2022 |
4
| Sachs Jessica (Chief Medical Officer) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 250,000 options to buy
@ $7.6, valued at
$1.9M
|
|
| 01/27/2022 |
4
| Kearns Evan (Chief Legal Officer) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 202,250 options to buy
@ $7.6, valued at
$1.5M
|
|
| 01/27/2022 |
4
| Robinson John Edward (Chief Scientific Officer) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 250,000 options to buy
@ $7.6, valued at
$1.9M
|
|
| 01/27/2022 |
4
| Robbins Andrew R (President and CEO) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 690,000 options to buy
@ $7.6, valued at
$5.2M
|
|
| 01/04/2022 |
4
| Sachs Jessica (Chief Medical Officer) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 674 shares
@ $6.817, valued at
$4.6k
|
|
| 01/04/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,329 options to buy
@ $8.7, valued at
$20.3k
|
|
|
|
|